New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
FHH

First Trust AlphaDEX U.S. Health Care Sector Index ETF

Passive ETFEquity

The FHH Exchange Traded Fund (ETF) is provided by First Trust. It is built to track an index: StrataQuant Health Care Index. The FHH ETF provides physical exposure, so by buying it you actually own parts of all the 72 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$50.46
-$0.94 (-1.83%) yesterday
1:30 PM 10/19/26 Closed
1D price range
$50.46$50.46
52W price range
$39.05$51.40
YTD Perf.
+20.59%
YTD Flows
Annualized volatility
Fund AuM
€5.3M
Share class AuM
€3.2M
TTM Yield
Tracking Error
Tracking Difference
ISIN
CA33718X1015
TER
0.76%
Inception date
10/30/2014
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Oct 16, 2026
-10%-5%0%5%10%15%20%25%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 08/31/26
Healthcare
98.23%
Unavailable
1.77%
Latest FHH news

No content available for this fund

FAQ about FHH

FHH is a Passive ETF. This ETF provides exposure to Other Large Cap US Health Care Equities.
FHH tracks the StrataQuant Health Care CAD Total Return Index - CAD, through a full replication replication method.
FHH carries a total expense ratio (TER) of 0.76%, indicating the annual cost for holding the fund.
FHH was introduced to the market on October 30, 2014. It trades on Canada
First Trust AlphaDEX U.S. Health Care Sector Index ETF, FHH, is provided by First Trust. Learn more about First Trust here.
FHH oversees €3.2M in assets as of October 16, 2026.
FHH follows a distributing dividend policy, meaning it pays out income to investors. As of October 16, 2026, its 12-month trailing yield was 0.48%.
As of August 31, 2026, FHH has significant geographic allocations in USA, Ireland and Netherlands.
As of August 31, 2026, FHH focuses largely on Healthcare.
As of August 31, 2026, FHH holds 72 positions in its portfolio, with 35.47% of assets concentrated in its top 15 holdings.
As of August 31, 2026, FHH top three holdings include Regeneron Pharmaceuticals, Inc., Pfizer Inc. and Solventum Corp..
The base currency of FHH is CAD.
Data as of 08/31/26
Regeneron Pharmaceuticals, Inc.
2.86%
Pfizer Inc.
2.56%
Solventum Corp.
2.55%
Natera, Inc.
2.55%
Zimmer Biomet Holdings, Inc.
2.49%
Universal Health Services, Inc.
2.48%
Boston Scientific Corp.
2.43%
Guardant Health, Inc.
2.37%
Tenet Healthcare Corp.
2.29%
The Cigna Group
2.22%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight